LIPL-1 and LIPL-2 are TCER-1-regulated lysosomal lipases with distinct roles in immunity and fertility Authors: Laura Bahr, Francis R.G. Amrit, Paige Emily Silvia, Bella Wayhs, Guled Ali Osman, Mayur Nimbadas Devare, Hannah Henry, Danny Bui, Mirae Choe, Nikki Naim, Margaret Champion, Yuxuan Man, Carissa Perez Olsen, Arjumand Ghazi, Pablo Wappner, Pablo Wappner, Pablo Wappner Published: 2025 ABSTRACT Reproduction and immunity are energy intensive processes that often compete for resources, leading to trade-offs across species. Lipid metabolism integrates these processes, particularly during stressful conditions such as pathogenic infections, yet the underlying molecular mechanisms remain poorly understood. TCER-1, the C. elegans homolog of mammalian TCERG1, suppresses immunity and promotes fertility, especially upon maternal infection. Here, we show that TCER-1 coordinates this balance by regulating two conserved lysosomal lipases, lipl-1 and lipl-2. Using transcriptomic, lipidomic, and molecular-genetic analyses, we demonstrate that both lipases mediate infection-induced lipid remodeling but with distinct outcomes: lipl-1 promotes immunity, whereas, lipl-2 does not. LIPL-1 catalyzes the accumulation of specific ceramide species, including Cer 17:1;O2/24:0, whose supplementation rescues the immunity phenotypes of tcer-1;lipl-1 mutants and enhances post-infection survival of wild-type animals. Both lipases influence fertility with lipl-2 playing a key role in maintaining embryonic-eggshell integrity during maternal infection and aging. Remarkably, expression of human lysosomal acid lipase (hLAL/LIPA), the ortholog of ‘lipl’ genes, restores immunity defects triggered by lipl-1 loss and enhances immune resilience but does not significantly ameliorate the fertility defects. Together, these findings reveal distinct roles for lipl-1 and lipl-2 in modulating lipid species that link immune defense, reproductive fitness and healthspan through a potentially conserved mechanism. Introduction Reproduction and immunity are intimately interconnected across species, from insects to humans, and often exhibit antagonistic interactions. In many species, infections reduce fertility, whereas, increased reproductive effort suppresses immune fitness [1,2]. However, exceptions exist as mating in some species triggers beneficial immune remodeling and heightened immune response [3,4], and male-derived factors can confer a survival advantage on females during post-mating infections [5]. In women, pregnancy was once considered to be a state of generalized immunosuppression but is now recognized to involve finely tuned immune adaptations that are essential from implantation through parturition, yet may also impair defense against certain pathogens [6–9]. Importantly, the intense metabolic demands of immunity and reproduction necessitate that these processes are tightly coregulated with energy metabolism [10,11]. Indeed, immune remodeling during pregnancy is partially driven by lipid metabolism, whereas, dysregulated energy metabolism underlies many pregnancy complications, including gestational diabetes and preeclampsia, the most common pathologies of human pregnancy in the developed world [12–14]. Thus, lipid metabolism emerges as a crucial arbiter of reproductive fitness and immune health coordination. The molecular mechanisms linking lipid remodeling, immunity, and reproduction are poorly understood. In mammals, complexities of pregnancy, low fecundity, and long gestations hinder mechanistic studies, whereas, they have been more tractable to investigations in invertebrates [1,15]. The nematode model, Caenorhabditis elegans, offers unique advantages because its short generation time and high reproductive output (~300 eggs over 3–6 days) allow sensitive detection of even minor fertility shifts under immune stress and vice versa [15–18]. For instance, maternal bacterial infection rapidly mobilizes lipids to the germline to support progeny but results in diminished maternal immune resistance [19–21]. Moreover, despite a simple immune system, C. elegans retains conserved immune signaling pathways, and many established infection models exist [22–27]. Previously, we identified TCER-1, C. elegans homolog of a mammalian transcription elongation and splicing factor, TCERG-1 [28,29], as a longevity-enhancing protein, that promotes fertility while suppressing immune responses in reproductively active animals [16]. Pertinently, TCER-1 supports reproductive success during immune challenges, as tcer-1 loss-of-function (lof) mutants exhibit reproductive defects, whereas, TCER-1 overexpression partially mitigates the fertility loss associated with maternal infection [16]. TCER-1’s role in coordinating reproduction, immunity, and aging appears to be evolutionarily conserved as inactivation of its Arabidopsis thaliana homologue, PRP40, enhances tolerance towards pathogens and delays flowering [30]. Mammalian TCERG1 is highly expressed in reproductive tissues, and similar to C. elegans TCER-1, declines with age in mouse and human oocytes [31,32]. We showed that TCER-1, along with pro-longevity transcription factors, DAF-16 and NHR-49, increases lifespan upon germline loss through concomitant enhancement of lipid anabolism and catabolism [33,34]. We have now discovered that TCER-1 impairs immunity and promotes fertility, in part through regulation of lysosomal lipases, lipl-1 and lipl-2, two of eight members of the conserved ‘lipl’ lipase family orthologous to the lysosomal acid lipase (LAL/LIPA) in humans [35,36]. The ‘lipl’ genes have been linked to nutrient stress responses, with lipl-1 and lipl-3 reported to mobilize fats during starvation [37], lipl-2 and lipl-5 to mediate metabolic remodeling upon dietary restriction [38–40] and lipl-4 to promote longevity by activating a lysosomal-nuclear retrograde signaling pathway [41–43]. Notably, lipl-1, lipl-2, lipl-3, and lipl-5 have been reported to be induced by pathogens such as Enterococcus faecalis, Staphylococcus aureus, Cryptococcus neoformans, and lipl-2 is differentially expressed during Bacillus thuringiensis infection [43–45]. Yet, their functional roles in innate immune response remain unknown. In this study, we show that TCER-1 regulates lipl-1 and lipl-2 expression upon infection by the human opportunistic Gram-negative pathogen, Pseudomonas aeruginosa strain PA14 (PA14) [27,46]. These lipases perform distinct functions in influencing immunity, reproduction, and longevity, and exert discrete effects on the animal’s lipid composition. lipl-1 enhances pathogen resistance, whereas lipl-2 does not and, in fact, appears to limit immunity and longevity. Both lipases contribute towards fertility success, but lipl-2 is especially critical for maintaining embryonic-eggshell integrity during maternal infection and aging. Notably, LIPL-1 and LIPL-2 influence the levels of individual lipid species that have been linked to stress resistance, lifespan, healthspan and reproductive outcomes. LIPL-1 drives the elevation of several specific ceramide species in tcer-1 mutants, including Cer 17:1;O2/24:0, whose supplementation rescues the immunity phenotypes of tcer-1;lipl-1 mutants and enhances post-infection survival of wild-type animals. Lastly, we show that human hLAL/LIPA rescues lipl-1 lof-associated immune defects and enhances worm survival upon PA14 infection but does not compensate for fertility phenotypes. Altogether, these findings provide evidence for discrete roles of LIPL-1 and LIPL-2 in C. elegans fertility and immunity, and as central effectors of TCER-1 in coordinating immune, reproductive, and aging processes. Results TCER-1 broadly remodels lipid metabolism in response to pathogenic infection in C. elegans To elucidate the transcriptomes dictated by TCER-1 under uninfected conditions and upon pathogenic infection, we performed RNA-Seq on wild-type (WT) animals and tcer-1(tm1452) mutants that were exposed to PA14 for 8h and those maintained on standard Escherichia coli strain OP50 (OP50) lawns (Fig 1A). Analysis of the sequencing data using the CLC Genomics Workbench (S1 Table; see Methods for details) revealed that pathogen exposure triggered differential expression of 1002 genes in WT animals (Tab A in S1 Table) of which 583 were upregulated (Tab Ai in S1 Table) and 419 were downregulated (Tab Aii in S1 Table). tcer-1 mutants showed differential expression of 159 genes as compared to WT on the normal OP50 diet (Tab B in S1 Table) with 78 being upregulated (Tab Bi in S1 Table) and 81 being downregulated (Tab Bii in S1 Table). The expression of 306 genes was altered upon comparing WT animals and tcer-1 mutants after PA14 exposure (Tab C in S1 Table), of which 156 were upregulated (Tab Ci in S1 Table) and 150 were downregulated (Tab Cii in S1 Table). 962 genes were differentially expressed by tcer-1 mutants on OP50 vs. PA14 (Tab D in S1 Table) with 707 upregulated (Tab Di in S1 Table) and 255 downregulated (Tab Dii in S1 Table) (Fig 1B). TCER-1 regulates lipid metabolism upon PA14 infection. A) RNAseq experimental paradigm. Age-matched wild type (WT) and tcer-1 L4s raised on OP50 exposed to PA14 for 8 hours. B) Overlaps of groups of differentially expressed genes (DEGs) identified. C-F) Overlap of genes upregulated (C, D) and downregulated (E, F) upon PA14 exposure with previously-identified PA14-responsive genes by Troemel et al. 2006 [27]. RF: Representation Factor. Statistical significance of overlap between gene sets calculated using hypergeometric probability formula with normal approximation (see Methods). Comparisons with additional studies in S2 Fig and S2 Table. G) Gene ontology (GO) term analysis of PA14- and TCER-1- driven DEGs using WormCat. Metabolism (Category 1), particularly lipid metabolism, (Category 2) (blue boxes) identified as differentially impacted processes amongst genes upregulated (UP, left) and downregulated (DOWN, right) in infected WT and tcer-1 mutants. Key shown in middle (black box). H-L) lipl-1 and lipl-2 are transcriptionally upregulated in tcer-1 mutants on PA14 infection and lipl-3, lipl-4 and lipl-5 are downregulated. mRNA levels of lipl-1 (H), lipl-2 (I) lipl-3 (J), lipl-4 (K) and lipl-5 (L) measured by qPCR in WT and tcer-1 mutant (blue) adults maintained on OP50 (solid bars) or exposed as L4s to PA14 for 8 h (hashed bars). Data from at least 3 independent trials/biological replicates. Asterisks represent statistical significance of differences observed in unpaired, two-tailed t-tests with P values * ≤ 0.05, *** p ≤ 0.001 and ****p ≤ 0.0001. PA14-induced gene expression changes have been described in previous reports, and we found a substantial overlap between these datasets and our PA14-induced gene lists. For instance, 230 of 310 genes (74%) found to be upregulated 4 hours after PA14 infection by Troemel et al., were also upregulated in our study (Representation Factor (RF): 22.4, p < 1.738e-288) as were 196 of 269 genes (73%) upregulated after 8 hours of infection (RF: 22.0, p < 3.383e-240) (Fig 1C and 1D and S2 Table) [27]. 71 of 117 (61%; RF: 25.4, p < 4.583e-86) and 93 of 134 (69%; RF: 29.1, p < 6.255e-122) genes downregulated post-infection at 4 hours and 8 hours, respectively, in the same study were also downregulated on PA14 in our experiment (Fig 1E and 1F and S2 Table) [27]. Similarly significant overlaps were observed upon comparison with PA14-dependent genes identified by other studies (S1 Fig and S2 Table) [26,47]. These comparisons reinforced our confidence in the transcriptomes that we mapped, including the hundreds of newly- identified PA14 responsive genes, as well as the TCER-1 downstream targets. Gene Ontology (GO) assessment and analyses with WormCat, a C. elegans gene enrichment analysis tool [48], both revealed enrichment of innate immunity, stress response, and metabolic processes, particularly lipid metabolism, within the PA14- and TCER-1- dependent differentially expressed genes (DEGs) as previously reported (Figs 1G and S2 and Tabs A–D in S1 Table) [33,44]. Notably, five of the eight members of the C. elegans ‘lipl’ family of lipase genes were affected by these interventions, forming two subsets with contrasting regulation. In WT animals, PA14 infection upregulated lipl-1 and lipl-2, whereas lipl-3, lipl-4, and lipl-5 were downregulated (Tabs Ai and Aii in S1 Table). These findings were confirmed by quantitative PCR (Fig 1H-1L). Importantly, tcer-1 mutants displayed a markedly greater induction of lipl-1 and lipl-2 upon infection compared to WT animals (Fig 1H and 1I). This trend was also reflected in the WormCat output. ‘Metabolism’ (Category 1) was enriched amongst DEGs of both WT and tcer-1 mutants’ PA14 response, but the enrichment was stronger and more significant in tcer-1 mutants- mirroring the mutants’ heightened induction of lipl-1 and lipl-2 (Figs 1G and S2). We focused on lipl-1 and lipl-2 because PA14 infection and TCER-1 appeared to exert opposite effects on their expression, and this contrasting regulation implied a potential role for these genes in the TCER-1- dependent tradeoff between immunity and fertility. In particular, the exaggerated upregulation of lipl-1 and lipl-2 in tcer-1 mutants suggested that in WT, infected adults these genes may be induced as part of the immune response but get curtailed by TCER-1, whereas, upon tcer-1 depletion, this repression is eliminated and immune response further heightened. TCER-1 differentially regulates lipl-1 and lipl-2 expression in adult tissues upon pathogen exposure We next sought to identify the tissues and cells where lipl-1 and lipl-2 expression was being modulated. In a previous study, a 441 bp lipl-1 promoter-driven transgene was reported to be expressed in intestinal cells [37]. We created transgenic animals expressing mCherry driven by this promoter [lipl-1p(441 bp):mCherry]. Under uninfected conditions, lipl-1 expression was observed at low levels in WT adults with fluorescence localized to the intestine and, less frequently, in the head (Figs 2A and S3). Within the transgenic population, fluorescence intensity ranged from quite dim, and primarily visible in the posterior intestine, to very bright throughout the intestine and neurons. Most animals exhibited an intermediate level of fluorescence (Figs 2A-2F and S3). The fraction of worms showing high intestinal fluorescence was increased significantly upon tcer-1 RNAi as well as PA14 exposure (Fig 2A-2E), whereas, neuronal levels were not altered by either intervention (Fig 2F). Pathogen exposure following tcer-1 RNAi tripled and doubled the fraction of animals exhibiting high expression in the intestines and neurons, respectively (Fig 2E and 2F) as predicted by the RNAseq data. We created an additional reporter strain driving mCherry under control of 1kb of lipl-1 upstream region and found similar expression patterns (AGP340, see Methods) hence the 441 bp promoter reporter was used for subsequent studies. To examine how these transcriptional changes translated into protein levels and localization in vivo, we generated a transgenic strain expressing a fluorescent-tagged LIPL-1::RFP driven by the same 441 bp promoter. LIPL-1::RFP expression showed similar spatial distribution as the transcriptional reporter in intestinal cells, but at significantly lower levels. Expression in the head was punctate but highly inconsistent. Notably, expression was strongly localized to the coelomocytes (where the transcriptional reporter was not observed), suggesting that LIPL-1 protein may be secreted into the pseudocoelomic cavity (S4A-S4D Fig). While tcer-1 RNAi and PA14 exposure both appeared to induce modest increases in RFP levels, paralleling the mRNA expression, we were unable to quantify these data due to the high variability and low expression levels of the fluorescent signal. tcer-1 inactivation and pathogen exposure induce lipl-1 and lipl-2 transcriptional upregulation. A-F: lipl-1 transcriptional changes visualized in vivo using lipl-1p::mCherry. Animals raised on bacteria expressing control empty vector (Ctrl, A, C) or tcer-1 dsRNA (RNAi, B, D) until pre-adult, L4 larval stage and transferred to plates seeded with P. aeruginosa PA14 (PA14, C, D) or E. coli OP50 (OP50, A, B) and incubated for 8h at 25 °C. Expression visible in intestine and head; in a WT adult population, varied from low levels to high or very high fluorescence intensities in intestine and head, respectively (categorization and quantification detailed in S3 Fig). Fraction of population with high or very high expression quantified in intestine (E) or head (F). E: Control (Ctrl) RNAi, OP50 (n = 81, 3.7%), tcer-1 RNAi, OP50 (n = 83, 21.69%), Ctrl RNAi, PA14 (n = 69, 23.19%), tcer-1 RNAi, PA14 (n = 68, 58.82%). F: Ctrl RNAi, OP50 (n = 81, 10.52%), tcer-1 RNAi, OP50 (n = 83, 7.895%), Control RNAi, PA14 (n = 69, 7.895%), tcer-1 RNAi, PA14 (n = 67, 23.68%). G-K: lipl-2 transcriptional changes visualized in vivo using lipl-2p::mCherry. lipl-2 expression levels observed using the transcriptional reporter lipl-2p::mCherry. Animals were raised as described above. Expression visible predominantly in the intestine and varied from low to high fluorescence intensities (detailed in S5 Fig). K: Fraction of populations showing high intestinal expression. Ctrl RNAi, OP50 (n = 86, 1.16%), tcer-1 RNAi, OP50 (n = 83, 7.22%), Ctrl RNAi, PA14 (n = 81, 1.23%), tcer-1 RNAi, PA14 (n = 72, 12.5%). A-D and G-J show representative images pseudocolored with ImageJ LUT Fire. Comparisons performed using two-tailed Fisher’s exact test on contingency tables of data from 3 pooled biological replicates in both cases. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 and ****p ≤ 0.0001. To examine lipl-2 mRNA and protein localization in vivo, we similarly generated two mCherry-reporter strains driven by endogenous promoters (1kb and 1.5kb) and utilized a previously-published RFP-tagged strain (LIPL-2::RFP), respectively [39]. Both transcriptional reporters showed similar expression domains though the 1.5kb promoter-driven transgene showed more robust expression and was used to assess lipl-2 regulation. lipl-2 transcription was also most prominent in anterior and posterior intestinal cells with few animals showing head fluorescence (Figs 2G and S5). tcer-1 RNAi produced a modest elevation of intestinal reporter expression, whereas, PA14 exposure had no impact. Upon PA14 exposure in animals subjected to tcer-1 RNAi, lipl-2 expression in the intestine was strikingly elevated as compared to animals on control RNAi (Figs 2G, 2J, 2K, S5A, and S5B). No changes in expression were observed in the head. Interestingly, and unlike lipl-1, lipl-2 exhibited age-related expression dynamics with higher expression observed during larval stages followed by a marked decrease in young adulthood and a subsequent induction with age, by Day 5, in posterior intestinal cells (S5C Fig). LIPL-2::RFP signal was very low in WT adults, localized primarily to the intestine and coelomocytes and with punctate, head fluorescence observed in a small number of animals; it was not visibly or quantifiably altered by PA14 or tcer-1 lof (S4E-S4H Fig). LIPL-1, but not LIPL-2, is essential for the enhanced pathogen resilience of tcer-1 mutants We sought to determine the physiological impact of lipl-1 and lipl-2 on the immune response against PA14. Survival experiments using publicly available, partial deletion mutants of the two genes yielded highly inconsistent results, so we used CRISPR-Cas9 to create complete deletion alleles of both genes (see Methods for details). We found that lipl-1 was essential for the enhanced immune resistance of tcer-1 mutants; in 4/5 trials, tcer-1;lipl-1 mutants died significantly faster than tcer-1 mutants and in 3 of these tcer-1 mutants’ enhanced resistance was completely abolished (Fig 3A and S3 Table). lipl-1 single mutants’ survival was not significantly different from that of WT animals (Fig 3A and S3 Table). Genes that enhance stress resistance, including immune stress, often increase longevity so we assessed the impact of lipl-1 and lipl-2 deletions on lifespan on the regular OP50 diet [49–54]. lipl-1 deletion did not alter lifespan consistently, either alone or in a tcer-1 mutant background (Fig 3B and S4 Table). lipl-2 inactivation had unexpected, contrasting effects on immune resistance and longevity compared to lipl-1. The knockout did not suppress tcer-1 mutants enhanced pathogen resistance and instead tended towards increasing it further (Fig 3C and S3 Table). tcer-1;lipl-2 mutants showed lifespan extension on an OP50 diet compared to tcer-1 mutants (Fig 3D and S4 Table). Together, these data suggest that lipl-1 and lipl-2 have distinct, context-dependent effects on immunity and longevity. lipl-1 promotes immunity, especially upon tcer-1 inactivation, but does not affect lifespan, whereas, lipl-2 suppresses immunity and longevity, especially upon tcer-1 lof. tcer-1 mutants’ enhanced immunity is dependent upon lipl-1 but not lipl-2. A, B: Impact of lipl-1 deletion on survival upon pathogen infection and lifespan. Survival of wild type (WT, black), tcer-1 (blue), tcer-1;lipl-1 (dark green) and lipl-1 (light green) raised on OP50 till L4 stage and exposed to PA14 (A) or retained on OP50 (B). A: WT (m = 51.13 ± 1.32, n = 86/113), tcer-1 (m = 70.61 ± 2.09, n = 87/112), lipl-1 (m = 52.17 ± 1.1, n = 102/134), tcer-1;lipl-1 (m = 56.04 ± 1.23, n = 85/120). B: WT (m = 14.96 ± 0.34, n = 94/121), tcer-1 (m = 14.23 ± 0.48, n = 92/120), lipl-1 (m = 15.79 ± 0.57, n = 80/106), tcer-1;lipl-1 (m = 15.36 ± 0.51, n = 77/120). C, D: Impact of lipl-2 deletion on survival upon pathogen infection and lifespan. Survival of wild type (WT, black), tcer-1 (blue), tcer-1;lipl-2 (grape) and lipl-2 (magenta) raised on OP50 till L4 stage and exposed to PA14 (C) or retained on OP50 (D). C: WT (m = 51.13 ± 1.32, n = 86/113), tcer-1 (m = 70.61 ± 2.09, n = 87/112), lipl-2 (m = 70.64 ± 1.5, n = 61/123), tcer-1; lipl-2 (m = 78.23 ± 2.66, n = 66/124). D) Lifespan on OP50. WT (m = 14.96 ± 0.34, n = 94/121), tcer-1 (m = 14.23 ± 0.48, n = 92/120), lipl-2 (m = 15.93 ± 0.56, n = 89/113), tcer-1;lipl-2 (m = 16.72 ± 0.58, n = 81/103). Data from additional PA14 survival and lifespan trials in S3 and S4 Tables, respectively. Statistical significance was determined using log-rank Mantel Cox method and shown in each panel next to a given strain/condition. Asterisks are color coded to indicate the strain/condition being used for the comparison. p ≤ 0.05(*), p < 0.01 (**), < 0.001 (***), < 0.0001 (****). LIPL-1 and LIPL-2 are essential for embryonic eggshell integrity and reproductive fitness Since TCER-1 promotes fertility, we examined the effects of lipl-1 and lipl-2 inactivation on reproductive fitness in C. elegans. The deletion of either lipl-1 or lipl-2 further aggravated the reduced progeny number (brood size) of tcer-1 mutants significantly (Fig 4A). Further, inactivation of either lipl-1 or lipl-2 induced sterility in tcer-1 mutants (Fig 4B). tcer-1;lipl-1 and tcer-1;lipl-2 mutants also displayed a reduction in the number of eggs that hatched into healthy larvae (hatching) (Fig 4C). In tcer-1;lipl-2 lipl-1 triple mutants, brood size was further diminished (Fig 4A), whereas, the impacts on sterility and hatching were not significant (Fig 4B and 4C). In the presence of a functional TCER-1, deletion of either lipl-1 or lipl-2 alone, or together, did not cause sterility or impair hatching (Fig 4B and 4C). However, a modest reduction in brood size was manifested in both single mutants which was not accentuated further in the lipl-2 lipl-1 double knockout (Fig 4A). lipl-1 and lipl-2 lof result in decreased brood size, sterility, and embryonic inviability, particularly in combination with tcer-1 lof. A-C: Comparisons of maternal reproductive success in wild type (WT, black), lipl-1 (light green), lipl-2 (pink), lipl-2 lipl-1 (light brown), tcer-1 (blue), tcer-1;lipl-1 (dark green), tcer-1;lipl-2 (grape) and tcer-1;lipl-2 lipl-1 (dark brown) strains. A: Brood size: Total number of live progeny counted per worm per strain. Each dot represents one worm from an aggregate of 3 independent trials. WT (n = 28, m = 330.9 ± 59.19), lipl-1 (n = 29, m = 275.8 ± 51.97), lipl-2 (n = 23, m = 288.2 ± 39.97), lipl-2 lipl-1 (n = 24, m = 316.3 ± 33.23), tcer-1 (n = 25, m = 236.2 ± 97.14) tcer-1;lipl-1 (n = 23, m = 68.09 ± 68.12), tcer-1;lipl-2 (n = 36, m = 99.31 ± 116.1), tcer-1;lipl-2 lipl-1 (n = 20, m = 32.80 ± 44.87). B: Sterility: Percentage of animals which never produced a live progeny counted for each strain. WT (n = 28, m = 0), lipl-1 (n = 29, m = 0), lipl-2 (n = 23, m = 0), lipl-2 lipl-1 (n = 24, m = 0), tcer-1 (n = 25, m = 0), tcer-1;lipl-1 (n = 23, m = 27.48 ± 8.82), tcer-1;lipl-2 (n = 36, m = 48.87 ± 27.60), tcer-1;lipl-2 lipl-1 (n = 20, m = 30.67 ± 9.81). C: Hatching: calculated from [#progeny/(#progeny+ unhatched eggs)]. WT (m = 99.01 ± 0.29), lipl-1 (m = 97.09 ± 1.24), lipl-2 (m = 98.81 ± 0.65), lipl-2 lipl-1 (m = 99.47 ± 0.15), tcer-1 (m = 97.75 ± 1.36), tcer-1;lipl-1 (m = 59.95 ± 18.07), tcer-1;lipl-2 (m = 81.75 ± 7.78), tcer-1;lipl-2 lipl-1 (m = 74.79 ± 3.24). Data obtained from 3 independent trials in all cases. D-F: Embryonic eggshell defects induced by tcer-1, lipl-1 and lipl-2 inactivation. Representative images of embryos expressing cpg-2p::mCherry::CPG-2 and pie-1p::GFP::PH PLC1delta1, labeling eggshell chondroitin proteoglycan layer and embryonic plasma membrane, respectively, incubated with lipid-labeling dye, BODIPY. D: BODIPY is excluded in healthy embryo with intact lipid-permeability barrier (LBP) and CPG-2 is sequestered away from the embryo, in a characteristic ‘wavy’ pattern in the perivitelline space of the eggshell. E: Embryo with defective LPB exhibits widespread BODIPY staining, and mCherry::CPG-2 which freely diffuses between the outer eggshell and the embryo. F: Quantification of BODIPY-permeable embryos. Average fold-change of the fraction of BODIPY stained embryos laid by Day 4 mothers, normalized to tcer-1 mutants. tcer-1 (n = 1964, m = 0), WT (n = 1930, m = 0), lipl-1 (n = 2811, m = 0.7153 ± 0.7889), tcer-1;lipl-2 (n = 1940, m = 6.222 ± 3.030), tcer-1;lipl-1 (n = 2257, m = 1.563 ± 1.587), lipl-2 (n = 2546, m = 2.244 ± 1.980). Data obtained from 4 independent trials in all cases except lipl-2 for which 3 trials were conducted. In A-C, statistical significance was calculated using one-way ANOVA with Tukey’s correction. In F, student’s t-test was used. p ≤ 0.05(*), p < 0.01 (**), < 0.001 (***), < 0.0001 (****). Next, we examined the integrity of the embryonic eggshell, a protein and lipid rich structure critical for normal growth and development as it protects the embryo from mechanical and osmotic disruptions [55,56]. In particular, the innermost layer of the eggshell, a fat-rich lipid-permeability barrier (LPB) serves as a deterrent against unregulated influx of external materials [55]. Hence, WT embryos are impermeable to lipid-staining dyes such as BODIPY or FM-64; when LPB is disrupted, the eggshell becomes permeable to these molecules and fluorescence can be observed within the embryonic body (Fig 4D and 4E) [57,58]. Embryonic porosity towards lipid dyes serves as a valuable measure of LPB and eggshell integrity. In WT animals, we did not find any embryos that were permeable to BODIPY when laid by young, Day 1 mothers, or reproductively older Day 4 ones (Figs 4F and S6). However, embryos laid by Day 4 mothers carrying tcer-1 or either ‘lipl’ deletion produced a small but consistent fraction of eggs that accumulated BODIPY. The percent of porous eggs was not significantly increased in the tcer-1;lipl-1 double mutants. In contrast, this population was enhanced by up to tenfold in tcer-1;lipl-2 mutants (Fig 4F). Indeed, lipl-2 and tcer-1;lipl-2 mutants not only laid BODIPY-penetrable eggs on Day 4 of adulthood but also on Day 1 (S6 Fig). Altogether, these data suggested that both lipases promote fertility in WT animals and tcer-1 mutants, with lipl-2 exerting a greater impact, and their absence leads to defective eggshell formation that may contribute to reduced embryonic viability and fertility defects. TCER-1 and LIPL-2 Influence the relative distribution of neutral lipid populations To decipher the molecular changes brought about by TCER-1 on the animals’ lipid profile, and assess the contributions of LIPL-1 and LIPL-2, we performed high performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS) on young Day 1 WT adults and age-matched tcer-1, tcer-1;lipl-1 and tcer-1;lipl-2 strains as well as lipl-1 and lipl-2 single mutants. HPLC-MS/MS allowed us to identify the impact of the genes on the abundance and relative distribution of major neutral lipid (NL) and phospholipid (PL) classes as well as individual lipid species within those classes. Within the global NL population, tcer-1 mutants exhibited a significant shift in the relative abundance of the triacylglyceride (TAG) vs. diacylglyceride (DAG) levels. Compared to WT animals, their relative TAG content was increased by 15–20%, whereas, DAG levels were concomitantly decreased (Fig 5A and 5B). Interestingly, lipl-2 single mutants showed a similar change in TAG:DAG distribution. tcer-1;lipl-2 double mutants showed a small increase as compared to either genes’ single mutant but this did not achieve statistical significance. In contrast, lipl-1 inactivation had little impact in either WT or tcer-1 mutant backgrounds (Fig 5A and 5B) suggesting that, amongst the two lipases, lipl-2, but not lipl-1 shaped the TAG:DAG distribution. lipl-1 and lipl-2 have both shared and distinct impacts on the lipidome of tcer-1 mutants. A-C: Effects of lipl-1 (A) and lipl-2 (B) loss on broad neutral lipid (NL) and phospholipid (PL) populations in wild type (WT, black) and tcer-1 mutant (blue) animals. Bars indicate the fold-change of each data point normalized to the WT average. Statistical significance calculated using mixed-effects analysis with Tukey’s correction. C: Relative abundance of overall phosphatidylcholine (PC) levels. D: Categorization of NL (top, blue) and PL (bottom, green) species whose abundance is altered in tcer-1 mutants. For each class, number of species identified and those changed in tcer-1 mutants shown in the table. E: Relative abundance of PC 34:2 and PC 34:3 compared to all PCs in different strains. F-I: Distinct impacts of lipl-1 (F-H) and lipl-2 (I) on lipidome of tcer-1 mutants. F-H: Relative abundance of Cer 17:1;O2/22:0 (Cer 22) (F), Cer 17:1;O2/24:0 (Cer 24) (G) and Cer 17:1;O2/26:0 (Cer 26) (H) compared to all ceramides. I: Relative abundance of lysophosphatidyl choline (LPC) 18:2 compared to all LPCs. Data derived from HPLC-MS/MS analysis of Day 1 young adult hermaphrodites isolated in 5–6 independent biological trials. Statistical significance was calculated using two-way ANOVA with Tukey’s correction. J-K: Ceramide supplementation enhances survival upon PA14 infection. Survival of wild type Ctrl (WT, black), lipl-1;tcer-1 ctrl (green), lipl-1;tcer-1 + Cer 24 (Olive), WT + Cer 24 (Red) raised on OP50 till Day1 and exposed to PA14. J: WT ctrl (m = 63.09 ± 1.53, n = 74/90), lipl-1;tcer-1 ctrl (m = 58.1 ± 1.33, n = 82/90), lipl-1;tcer-1 + Cer 24 (m = 73.74 ± 2.0, n = 71/90). K: WT ctrl (m = 63.09 ± 1.53, n = 74/90), WT + Cer 24 (m = 70.57 ± 1.78, n = 58/90). Data from additional PA14 survival trials in S7 Table. Statistical significance was determined using log-rank Mantel Cox method and shown in each panel next to a given strain/condition. Asterisks indicate the statistical significance and their color the strain being used for the comparison. p ≤ 0.05(*), p < 0.01 (**), < 0.001 (***), < 0.0001 (****), n.s: not significant. LIPL-1 and LIPL-2 impact the levels of phospholipid species implicated in stress resistance and healthspan In contrast to NLs, the relative abundance of the major PL classes was not significantly altered in tcer-1 mutants except for a small but significant reduction in the levels of phosphatidylcholines (PC) (Figs 5C and S7). However, tcer-1 mutants manifested changes in the abundance of specific PL species’ head groups. Of the 39 lipid species significantly altered in tcer-1 mutants compared to WT animals, 30 were PLs and 9 were NLs. Amongst PLs, PCs were the most affected class as 12 of 50 identified species were altered in tcer-1 mutants- 7 were decreased and 5 increased (Fig 5D and S5 Table). Besides PCs, phosphatidylethanolamines (PE) were the most disrupted (10 of 56 species identified) followed by lysophosphatidylcholines (LPCs) and ceramides (Cer) (Fig 5D and S5 Table). While neither lipl-1 nor lipl-2 deletion affected the total PC abundance in tcer-1 mutants, single mutants of both genes showed a small but significant reduction in overall PC levels compared to WT (S7C and S7D Fig) and influenced the overall saturation of the associated fatty acid chains in the NL and PL populations (S8 and S9 Figs). lipl-1 and lipl-2 had shared impacts on the levels of two PCs, PC 34:2 and PC 34:3, both of which were significantly elevated in the tcer-1;lipl-1 and tcer-1;lipl-2 double mutants as compared to the tcer-1 single mutants (Fig 5E and S5 Table). Notably, lipl-1 and lipl-2 also exerted distinct effects on tcer-1 mutants’ lipidome, most strikingly on the Cer and LPC compositions. tcer-1 mutants showed increased levels of three Cer species, C17:1;O2/22:0 (Cer 22), Cer 17:1;O2/24:0 (Cer 24) and Cer 17:1;O2/26:0 (Cer 26) (Figs 5F-5H and S10 and S5 Table). The elevation of Cer 22 and Cer 24 was significantly reduced in tcer-1;lipl-1, whereas, Cer 26 levels were further elevated. tcer-1;lipl-2 mutants showed levels of all three species like tcer-1 (Figs 5F-5H and S10 and S5 Table). LIPL-2 had a similarly distinct impact on the abundance of LPC 18:2, which has been identified as a biomarker of healthspan and lifespan in human and C. elegans, respectively [59,60]. LPC 18:2 levels were significantly enhanced in tcer-1 mutants (Fig 5I and S5 Table). While lipl-2 single mutants showed a small reduction compared to WT, in tcer-1;lipl-2 mutants it was further elevated compared to tcer-1 alone. lipl-1 inactivation had no impact in either genetic background (Fig 5I and S5 Table). The impact of lipl-2 was specific to LPC 18:2 as two other LPCs, 17:1 and 19:1, that were depleted in tcer-1 mutants compared to WT, were not impacted by lipl-2 deletion (S5 Table). lipl-1 and lipl-2 single mutants also manifested overlapping as well as distinct lipidomic changes compared to WT (S6 Table). Altogether, these data showed that LIPL-1 and LIPL-2 had shared as well as discrete impacts on the lipidome, under normal conditions and upon tcer-1 inactivation. Importantly, they revealed the influences of these lipases on specific lipid moieties found previously to be associated with longevity and healthspan outcomes. Cer 24 supplementation extends the post-infection survival of tcer-1;lipl-1 mutants and WT adults The effects on Cer 22 and Cer 24 paralleled the requirement of lipl-1 for the enhanced PA14 resistance of tcer-1 mutants, suggesting potential immunity-promoting functions for these species. Amongst the Cer species elevated in tcer-1;lipl-1 mutants, we were able to commercially procure Cer 24 for supplementation studies. Exposing Day 1 tcer-1;lipl-1 adults to 60μg Cer 24 for 24 h before, and during, PA14 infection enhanced their survival substantially as compared to control animals exposed to solvent alone (Fig 5J and S7 Table) indicating a physiological relevance to the LIPL-1-mediated production of this species. We next asked if Cer 24 benefited WT animals and found their post-infection survival was also extended significantly upon Cer 24 supplementation (Fig 5K and S7 Table). To assess the roles of LIPL-2-derived species similarly elevated, we tested if LPC 18:2 improved WT survival on PA14 but found no impact upon its supplementation (S7 Table). Human lysosomal acid lipase (hLAL/LIPA) rescues immune deficits, but not the reproductive phenotypes induced by lipl-1 and lipl-2 mutations C. elegans LIPLs are predicted to be orthologs of several human lipases, including hLAL/LIPA that is expressed in mammalian immune cells such as macrophages [61] and is implicated in macrophage dysfunction, inflammatory signaling and lysosomal storage diseases [35,62]. To assess a potential functional homology between C. elegans LIPL-1 and LAL, we used MosSCI technology to express hLAL/LIPA in C. elegans and asked if the human protein could substitute for LIPL-1 in its immune function. We found that, upon PA14 infection, expression of hLAL in tcer-1;lipl-1 mutants completely rescued their survival to tcer-1 level (Fig 6A and S8 Table). In addition, transgenic strains expressing hLAL in somatic cells of WT C. elegans also survived substantially longer upon PA14 exposure (Fig 6B and S8 Table) suggesting a conserved immunity-promoting function. We next asked if hLAL/LIPA could rescue the fertility phenotypes associated with either lipl-1 or lipl-2 inactivation in tcer-1 mutants. These results were equivocal. hLAL/LIPA expression did not improve the brood-size defects of tcer-1;lipl-1 (Fig 6C). tcer-1;lipl-2 mutants expressing hLAL/LIPA showed a trend towards enhanced brood size compared to the double mutant alone, but this did not achieve statistical significance (Fig 6D). Similarly, the tcer-1;lipl-2 mutants’ embryonic permeability defects were marginally ameliorated but this was not statistically significant either (Fig 6E) indicating that hLAL/LIPA can substitute for the immunity-promoting ‘lipl’ function but likely not the fertility roles. Human Lysosomal Acid Lipase (hLAL/LIPA) rescues immune deficits induced by lipl-1 mutation and enhances survival upon PA14 infection. A: hLAL/LIPA rescues survival of tcer-1;lipl-1 mutants on PA14 exposure to tcer-1 level. Survival upon PA14 exposure from late-L4 stage onwards compared between wild type WT (black, m = 35.06 ± 1.91, n = 54/90), tcer-1 (blue, m = 54.8 ± 3.25, n = 63/90), tcer-1;lipl-1 (green, m = 36.65 ± 1.79, n = 52/90), tcer-1;lipl-1;hLAL (red, m = 55.77 ± 2.53, n = 73/90). B: hLAL/LIPA expression in C. elegans enhances survival upon PA14 infection. Survival upon PA14 exposure from late-L4 stage onwards compared between WT (black, m = 57.24 ± 2.01, n = 35/110) and two transgenic strains expressing hLAL broadly in somatic tissues. COP2983 (orange, m = 83.18 ± 2.22, n = 46/96) and COP2589 (red, m = 82.84 ± 2.22, n = 63/103). Data from additional trials in S8 Table. C-E: hLAL/LIPA does not rescue the reproductive defects of tcer-1;lipl-1 and tcer-1;lipl-2 mutants. Comparisons of reproductive success in wild type (WT, black), tcer-1;lipl-1 (green), tcer-1;lipl-2 (purple), tcer-1;lipl-1;hLAL (red) and tcer-1;lipl-2;hLAL (maroon) strains. C, D: Brood size: Total number of live progeny counted per worm per strain. Each dot represents one worm from an aggregate for two independent trials. C: WT (n = 15, m = 275.7 ± 16.37), tcer-1 (n = 15, m = 64.20 ± 18.40), tcer-1;lipl-1 (n = 15, m = 122.4 ± 6.80), tcer-1;lipl-1;hLAL (n = 15, m = 91.53 ± 11.99). D: WT (n = 26, m = 281.5 ± 26.43), tcer-1 (n = 25, m = 323.6 ± 21.83), tcer-1;lipl-2 (n = 23, m = 161.9 ± 23.66), tcer-1;lipl-2;hLAL (n = 26, m = 248.3 ± 21.53). E: Quantification of Embryonic egg-shell defects. Average-fold change of the fraction of BODIPY stained embryos laid by Day 4 mothers, normalized to tcer-1 mutants. WT (n = 126, m = 0.3687 ± 0.1515), tcer-1 (n = 30, m = 1.0 ± 0.1389), tcer-1;lipl-2 (n = 45, m = 1.741 ± 0.6080), tcer-1;lipl-2;hLAL (n = 36, m = 1.459 ± 0.2039). In A-B, statistical significance was calculated using the log-rank Mantel Cox method and is shown on each panel next to a given strain/condition with the color of the asterisk indicating strain being used for comparison. In C-D, statistical significance was calculated using one-way ANOVA with Tukey’s correction. In E, Student’s t-test was used. p ≤ 0.05(*), p < 0.01 (**), < 0.001 (***), < 0.0001(****), n.s: not significant. Discussion In this study, we identified lipl-1 and lipl-2 as mechanistic effectors of TCER-1, a transcriptional and splicing regulator that suppresses immunity and promotes fertility in C. elegans. Through transcriptomic, lipidomic, and genetic analyses, we show that these conserved lysosomal lipases perform distinct, context-specific roles in shaping immunity, reproduction, lipid profile, and lifespan (Fig 7). lipl-1 enhances immune resistance in tcer-1 mutants, whereas, lipl-2 does not. Instead, lipl-2 appears to limit longevity and immunity especially upon tcer-1 lof. Both lipases support fertility, especially embryonic integrity under infection stress, with lipl-2 playing a more prominent role. Their lipidomic impacts are characterized by shared features well as production of specific lipids found to be correlated with stress resistance, lifespan and healthspan. Amongst these, we identified Cer 24 as a LIPL-1-derived species that promotes immunity in infected animals. Further, we found that the human ortholog, LAL/LIPA, rescues lipl-1-associated immune defects and improves survival upon infection suggesting potential evolutionary conservation of these molecular functions. Schematic depicting the regulation of lysosomal lipases, lipl-1 and lipl-2, by TCER-1 and their distinct roles in immunity and fertility identified in this study. TCER-1 represses the expression of lipl-1 upon infection, which in turn modulates levels of the specific fatty-acid species, such as the Ceramide 24 (Cer 24) that promote immune resilience. lipl-1 also acts with TCER-1 to promote fertility (left panel). In contrast, the relationship between TCER-1 and lipl-2 appears more complex. Although TCER-1 represses lipl-2 induction upon infection, both genes repress immunity and promote fertility, suggesting that TCER-1 may act through additional pathways to coordinate these processes (right panel). Arrows denote activation, and blunt-ended lines denote repression. Figure created using Biorender. A particularly revealing aspect of our study is the alteration of specific, functionally relevant sphingolipid species in a lipase-dependent manner. LIPL-1 and LIPL-2 did not broadly alter global neutral lipid or phospholipid levels but instead modulated select species, notably ceramide sphingolipids. This aligns with growing evidence that overall fat or TAG levels are poor indicators of lifespan or stress resilience: long-lived insulin/IGF-1 mutants such as daf-2 and germline-ablated animals accumulate fat, whereas calorie-restricted animals are lean yet long-lived [63,64]. Here, we found that tcer-1 mutants accumulated bioactive ceramides Cer 22, Cer 24 and Cer 26 dependent on lipl-1 activity. Ceramides are essential membrane lipids with critical signaling roles [65,66], and distinct species in C. elegans have been linked to mitochondrial surveillance (Cer 24), heat-stress resistance (Cer 16), and germline ablation- induced longevity (GlcCer C22) [67–69]. The specificity of ceramide changes likely reflects the influence of their acyl chain composition, which affects lipid shape, protein interactions, and function. While alterations in ceramides associated with stress and longevity have previously been attributed to regulation of biosynthetic enzymes such as the ceramide synthase hyl-2, our RNA-seq data did not show the differential expression of hyl-2 or other sphingolipid biogenesis genes following pathogen infection or tcer-1 loss. Hence, these observed immune-related ceramide changes appear lipolysis-driven, consistent with ceramide generation by lysosomal lipases through breakdown of complex sphingolipids in mammals [70]. Importantly, Cer 24 supplementation restored tcer-1;lipl-1 mutants’ survival on PA14 and improved post-infection resilience in WT animals, underscoring the physiological significance of such specific lipid species. Analogously, in humans, distinct ceramides rather than total lipid content determine metabolic outcomes. For instance, elevated C16:0 and C18:0 ceramides correlate with insulin resistance and β-cell dysfunction in Type 2 Diabetes [71,72], whereas, exercise selectively reduces C16:0 and enriches very-long-chain ceramides (C24:0, C24:1), enhancing insulin sensitivity and mitochondrial capacity [73]. Together, these findings highlight that targeted remodeling of ceramide composition, not total fat content, underlies adaptive and pathological metabolic states. An unexpected finding of our study is the contrasting roles of lipl-1 and lipl-2 in immune defense. Our RNAseq data had led us to hypothesize that TCER-1 suppresses immunity by downregulating both lipl-1 and lipl-2 and we had thus envisaged a pro-immunity function for both genes. While tcer-1 mutants did show lipl-1 and lipl-2 transcriptional upregulation during PA14 infection, relative to uninfected animals, only lipl-1 was required for the enhanced pathogen resistance of tcer-1 mutants, not lipl-2. In fact, lipl-2 loss appeared to enhance post-infection survival and longevity in tcer-1 mutants, highlighting that transcriptional changes do not always reflect functional impact. We also observed discrepancies between in vivo mRNA and protein reporters, with low mRNA and very low protein in adult tissues, suggesting tight post-transcriptional control and rapid protein turnover. The lipases’ protein reporters localized to coelomocytes despite intestinal transcription, implying secretion- consistent with prior findings on LIPL-1, -3, and -5 [37,38]. Temperature also played a role: although tcer-1 lof consistently increased reporter expression in all conditions- matching gene expression data- the 25°C temperature required for PA14 virulence elevated reporter expression too, likely reflecting previously-described HSF-1- dependent heat shock response [74]. lipl-2 supports reproductive health, particularly eggshell integrity during infection. Strikingly, the combined loss of tcer-1 and lipl-2 caused even young mothers to lay defective embryos. These phenotypes are noteworthy considering the unique lipidomic changes we observed in tcer-1;lipl-2 mutants. The abundance of 7 lipid species was altered in tcer-1;lipl-2 mutants compared to tcer-1 alone. Of these, elevation of three species- LPC 18:2, PC 32:1, and PC 32:2- has been linked to adverse pregnancy outcomes in women [75,76]. Additionally, LPC 18:2 and PC 32:3, also elevated in tcer-1;lipl-2, are part of a panel of 8 serum biomarkers linked to human healthspan. In elderly individuals, higher LPC 18:2 levels predict slower decline in gait speed, while PC 32:3 correlates with reduced gait speed [60]. The ability of the hLAL/LIPA to substitute for lipl-1 in promoting immune resistance is promising because of its known roles in macrophage biology, wherein, it regulates inflammation and is essential for M2 macrophage polarization, which supports anti-inflammatory responses and tissue repair [61]. Its deficiency causes lipid storage disorders such as Wolman’s disease and cholesterol ester storage disease (CESD) and leads to tissue-specific inflammation [35]. In mice, LAL/LIPA deficiency leads to aberrant macrophage infiltration, while tissue-specific knockouts in the liver, intestine, and lung exhibit heightened inflammation in the affected tissues [77–79]. In our experiments, hLAL/LIPA did not produce a significant or reliable rescue of lipl-1 or lipl-2 lof fertility phenotypes. Although the effects of lipl-2 are complex, the lipidomic parallels between C. elegans LPC changes and human health metrics are compelling. Together with the rescue of lipl-1 lof immunity phenotypes by hLAL/LIPA, they raise the enticing possibility that these genes may play conserved roles in the immune-reproductive axis. Materials and methods C. elegans and bacterial strains All strains were maintained by standard techniques at 20°C or 15°C on nematode growth medium (NGM) plates seeded with an E. coli strain OP50. For experiments involving RNAi, NGM plates were supplemented with 1 mL 100 mg/mL Ampicillin and 1 mL 1M IPTG (Isopropyl β-D-1-thiogalactopyranoside) per liter of NGM. The main strains used in this study are listed in S9 Table. Generation of lipl-1 and lipl-2 reporter strains Translational Reporters: The lipl-2p::LIPL-2::RFP construct was a gift from Dr. Abhinav Diwan [39]. lipl-1p::LIPL-1::RFP was generated by amplifying 1,010 bp of the endogenous lipl-1 promoter and entire CDS using primers which introduced Xma1 and Acc65i cut sites and eliminated the CDS stop codon (S10 Table). This was cloned into the lipl-2p::LIPL-2::RFP in PDG219 construct using restriction enzyme cloning to replace the lipl-2 sequence. Transgenic strains were generated by injecting reporter constructs (25ng/μl) with a co-injection marker containing myo-2p:GFP (15ng/μl) Strains were maintained by picking green fluorescent worms. Transcriptional reporters: For each construct, the selected region of the lipl-1 (441 bp or 994 bp) or lipl-2 (1000 bp or 1500 bp) endogenous promoter was amplified using primers which added a homology region to the pAV1944 construct containing myo-2p:mCherry. pAV1944 was linearized with Nhe1 and Sph1 restriction enzyme digestion to excise the myo-2 promoter, and the final constructs were assembled using a Gibson assembly kit (NEB E5520S) according to manufacturer directions. Transgenic strains were generated by injecting a lipl- reporter construct (50 ng/μl) along with a co-injection marker (ofm-1p:GFP or myo-2p:GFP, 15ng/μl). Strains were maintained by picking green fluorescent worms. The translational reporter strains showed developmental variability and propensity for loss of transgenes across generations which can likely be attributed to their array-based construction. Primers used in this study are listed in S10 Table. Generation of lipl-1 and lipl-2 deletion mutants Strains were generated using the co-CRISPR method previously described [80]. Briefly, gRNAs and repair templates were designed to excise the entire CDS of lipl-1 or lipl-2 (S10 Table). Injection mix (10μl volume: 24μg Cas9, 20μg tracrRNA (IDT 1072533), 4μg each target gRNA, 500ng target repair template, 2μg dpy-10 crRNA, 250ng dpy-10 repair template, IDT Nuclease-free Duplex Buffer to 10μL) was freshly prepared and spun for 20 minutes at 12,000g. Young Day 1 adults were injected in the gonad, and monitored for dumpy-roller progeny. F1 larvae from dpy/rol plates were screened by PCR to identify heterozygous CRISPR deletion alleles, which were outcrossed to N2 thrice and homozygosed. Primers, gRNAs and repair templates used are listed in S10 Table. Generation of hLAL strains The transgenic strains COP2589 {knuSi924 [pNU3447 (eft-3p::hLIPA::linker::wrmScarlet::3xFLAG::tbb-2u in cxTi10882, unc-119(+)) IV; unc-119(ed3) III} and COP2593 {knuSi927 [pNU3447 (eft-3p::hLIPA::linker::wrmScarlet::3xFLAG::tbb-2u in cxTi10882, unc-119(+))} IV; unc-119(ed3) III} expressing hLAL/LIPA using the pan-somatic promoter, eft-3, were created by InVivo Biosystems using the Mos1-mediated Singly Copy Insertions (MosSCI) method which enables integration of a transgene as a single copy at a designated C. elegans locus [81]. The unc-119 rescue cassette was used to bring the transgene into a target Mos1 locus on chromosome IV and create rescue of the unc-119(ed3) mutant allele. The Mos1 locus was selected for position-neutral effects and to avoid the gene-coding regions, introns and transcription factor binding sites. Transgene integration was confirmed by PCR. Fluorescence imaging and quantification Transcriptional Reporters: Transgenic animals were immobilized with 20 mM Levamisole, mounted on agar pads and imaged using a Leica DM5500B compound scope at 20x. Image acquisition was performed using LAS X software (Leica). Images were processed using ImageJ software. Translational Reporters: Transgenic animals were immobilized with 20 mM Levamisole, mounted on agar pads and imaged using a Leica Stellaris 5 confocal with an integrated White Light Laser (WLL) at 20x and 63x. Image acquisition was performed using LAS X software (Leica). Images were processed using ImageJ software. Fluorescence intensity was quantified using the Lookup Table (LUT) ‘Fire’ feature applied to pseudocolor images. The LUT Fire gradient mapped pixel intensity from low to intermediate (red/yellow) to high (white) fluorescence, allowing visual discrimination of signal intensity across samples, differentiation between regions of comparable size but differing fluorescence levels and delineating true signal from background. Quantification was performed by measuring mean pixel intensity within defined regions of interest (ROIs) on identically processed images. Lifespan assays Lifespan experiments were performed as previously described [82]. All lifespan experiments were conducted at 20 °C on E. coli OP50 plates unless otherwise noted. Between 10–15 L4 hermaphrodites were transferred to each of ~5 − 6 plates per experiment and observed at 24 − 48 h intervals to document live, dead or censored (animals that exploded, bagged or could not be located) animals. Animals were scored as dead when they failed to respond to gentle prodding with a platinum wire pick. Fertile strains were transferred every other day to fresh plates until progeny production ceased. The program Online Application of Survival Analysis 2 (OASIS 2) [83] was used for statistical analysis of both lifespan and pathogen stress assays. P-values were calculated using the log-rank (Mantel–Cox) test and subjected to multiplicity correction in experiments that involved more than two strains/conditions. Results were graphed using GraphPad Prism (Version 8). PA14-infection survival assays Pathogenic bacterial strain Pseudomonas aeruginosa (strain PA14) was streaked from frozen stocks onto Luria Bertani (LB) agar, incubated at 37°C overnight and stored at 4°C for a week or less. Single colonies from the streaked plates were inoculated and grown in King’s Broth to exponential growth phase, 6–12 hours at 37 °C with shaking. ~ 20 µl of this broth culture was seeded onto slow killing (SK) plates (modified NGM plates containing 0.35% peptone instead of 0.25%) and incubated for 24 h at 37 °C. The plates were then left to sit at room temperature (RT) for 24 h prior to use. Between 30 and 40 L4 hermaphrodites per strain were transferred to each of ~3–5 PA14 plates, incubated at 25 °C and monitored at 6 − 12 h intervals to account for live, dead or censored animals as described above. To rule out the impact of internal hatching on experimental outcomes, L4 larval stage animals were treated with 100 μg per ml of Fluoro Deoxy Uridine (fUDR) on NGM plates with OP50. Exposing C. elegans to this treatment for 24 h at 200C before transferring to PA14 SK plates prevented the eggs from hatching, without significant impact on the strains’ survival dynamics (S7 Table). For experiments that also involved RNAi treatment, animals were grown to the L4 stage on standard RNAi plates seeded with E. coli HT115 strain carrying an empty vector control (pAD12 or L4440) or the relevant RNAi clone before transferring to PA14-seeded SK plates and assaying for survival at 25 °C. Kaplan−Meier analysis and statistics were performed as described above for lifespan assays. Lipid supplementation assays Cer 24 ceramide (Avanti Polar Lipids, Cat. No. 860649P) and lysophosphatidylcholine 18:2 (LPC 18:2; MedChemExpress, Cat. No. HY-N9410) were dissolved in ethanol to prepare stock solutions at a concentration of 0.5 mg/mL. For supplementation, 60μg of Cer 24 or LPC 18:2 (120 µL of the stock solution) was evenly applied to the surface of NGM plates prior to bacterial seeding. Control plates received an equal volume of ethanol (120 µL). L4-stage worms were transferred to either control or Cer 24 plates prior to infection, and Day 1 adults were subsequently exposed to the pathogen. Pathogen exposed worms were transferred daily to freshly prepared control or Cer 24 or LPC 18:2 plates. Reproductive-health assay Reproductive health was assessed using previously described methods [33]. All experiments were conducted at 20°C and when matricide/ bagging occurred the animal was censored from the experiment on that day. Individual synchronized L4 hermaphrodites were moved to fresh plates daily till the end of the reproductive phase (no progeny observed on a plate for a minimum of 2 days). Each day, once the parent was moved to a fresh plate, the older plate with eggs was stored at 20°C for ~48 hours, and the number of hatched worms and eggs counted to calculate brood size. The above two parameters were used to determine viability (ratio of the total number of eggs laid by a hermaphrodite in its lifetime to total number of eggs that hatched). Animals that failed to lay any viable embryos were defined as sterile and this fraction was used to estimate sterility in the population. The data presented was obtained from aggregation of two to three independent trials wherein at least 10–15 animals per strain were examined. Embryo permeability assessment For each genotype, approximately 20 gravid mothers were allowed to lay eggs overnight on 6 cm plates. After 12hrs, the mothers were removed, and 200μl working solution of 20μg/mL BODIPY (Invitrogen D3922) in Egg Buffer [4mM HEPES (pH 7.4), 94mM NaCl, 32 mM KCl, 2.7mM CaCl2 and 2.7mM MgCl2] was added to flood each plate. After the liquid was completely absorbed, embryos were immediately counted and screened for fluorescence using a Leica DM3000B microscope with a Lumen 200 metal halide fluorescence illuminator light box (Prior Scientific L200). For Day 4 experiments, the worms were transferred to fresh plates every day till Day 4 and then allowed to lay eggs before the same protocol was used. RNA-sequencing and data analysis RNA was isolated from 3 biological replicates of age-synchronized, Day 1 WT animals and CF2166 tcer-1(tm1452) mutants grown on OP50 till late L4 stage (~48h), then transferred to PA14 plates (grown as described above) or allowed to continue on OP50. After 8h of exposure, worms were harvested for RNA isolation from approximately 3000 worms per strain. Following 7 freeze thaw cycles, RNA was isolated using the Trizol method and for quality and quantity using the Agilent Tape station and Qubit Fluorometry. Sequencing libraries were prepared using the TruSeq stranded mRNA (PolyA+) kit and the samples were then subjected to 75 base pair paired-end sequencing on an Illumina NextSeq 500 sequencer at the Univ. of Pittsburgh Genomics Research Core. Sequencing data was analyzed using the CLC Genomics Workbench (Version 20.0.3) employing the RNA Seq pipeline. Differentially regulated genes were filtered for significant changes based on the criteria of >2 fold change in expression, P Value of <0.05 and a false discovery rate (FDR) of <0.05. Gene ontology analyses Genes that were differentially regulated in a statistically significant manner were classified into two groups as either up-regulated (UP) or down-regulated (DOWN) targets. These groups were analyzed for enrichment of gene classes based on Gene Ontology (GO) Terms using C. elegans centered publicly available online resources, Wormbase Gene Set Enrichment Analysis tool (https://wormbase.org/tools/enrichment/tea/tea.cgi) and WormCat (http://wormcat.com/) [84]. Representation Factor was calculated at http://nemates.org/MA/progs/overlap_stats.html. Lipidomics: Sample collection From each strain, ~ 5,000 young Day 1 adults were collected at approximate onset of egg lay. To obtain these, approximately 600 gravid mothers were placed on 10 cm plates seeded with OP50 and allowed to lay eggs for 5–8 hours, then moved to fresh plates to lay eggs overnight. The next day, all mothers were removed from overnight egg plates, and plates were subsequently monitored for onset of egg lay. WT, lipl-1, and lipl-2 young adults were collected by washing plates with M9. tcer-1, tcer-1;lipl-1, and tcer-1;lipl-2 strains exhibit delayed, unsynchronized development and significant infertility. To ensure that only fertile young adults were collected in these strains, once the population had abundant L4s, about 5,000 L4s were moved to a fresh 10 cm plate. The next day, only individuals with eggs were manually picked for the sample collection. Due to the labor-intensive nature of this approach, the sample collection was performed in two batches with WT and tcer-1 controls included in each batch: (i) WT, lipl-1, tcer-1, tcer-1;lipl-1 and (ii) WT, lipl-2, tcer-1, tcer-1;lipl-2. Five or six independent biological replicates were collected in each batch for each strain. Upon collection, worms were rinsed 2x with M9 and centrifugation (1000g x 2min). Final pellet was rinsed 1x with Millipore water and flash frozen. Lipid extraction Lipid extraction and detection of PL, NL and sphingolipids was carried out as described [85]. Briefly, for PLs, total lipids were extracted from nematodes strain using a chloroform/methanol (2:1 v/v) solvent system. A 1,2-diundecanoyl-sn-glyerco-3- phosphocholine standard was added for relative quantification prior to extraction (Avanti Polar Lipids). Total lipids were injected onto the LC-MS/MS system for the negative ion scanning mode analysis using an HPLC system (Dionex UHPLC UltiMate 3000) equipped with a C18 Hypersil Gold 2.1 × 50 mm, 1.9 μm column (25002–052130; Thermo Scientific) equipped with a 2.1 mm ID, 5 μm Drop-In guard cartridge (25005–012101; Thermo Scientific). Analysis was completed using a Q Exactive Orbitrap mass spectrometer coupled with a heated electrospray ionization source (Thermo Scientific). For extraction and detection of NLs, the same protocol was followed with minor changes. The standard for relative analysis was a triglyceride standard mix (GLC-406 Nu-Chek). Lipids were injected onto the HPLC-MS/MS system for the positive ion scanning mode analysis. For sphingolipid extraction and detection, a Ceramide/ Sphingoid Internal Standard Mixture I (Avanti Polar Lipids) was added to the nematode sample and total lipids extracted as previously mentioned using a chloroform:methanol mixture. Sphingolipids were separated and analyzed using the same instrument as PLs and NLs with the following modifications. 10 μl of the purified sphingolipids were injected onto the HPLC-MS/MS system for the positive ion scanning mode analysis. For MS analysis, the following parameters were used: the capillary temperature was set at 275 °C, the sheath gas flow rate was set at 45 units, the auxiliary gas flow was set at 10 units, the source voltage was 3.2 kV, and the AGC target was 106. Acquisition was carried out with full-scan data-dependent MS2 (ddMS2) mode. For MS1 profiling, scans were run at a resolution of 70k. MS2 analyses were performed using five scan events, where the top five ions were chosen from an initial MS1 scan. For fragmentation, a normalized collision energy of 50 was used. MS1 spectra were collected in profile mode, whereas MS2 spectra were collected in centroid mode. Overall, for the strains lipl-1, lipl-2, tcer-1; lipl-1 and tcer-1; lipl-2, between 4–6 successful MS runs were conducted and for WT and tcer-1 data obtained from 7 to 10 successful MS runs was used for subsequent analysis. Data analysis Lipid analysis of the LC-MS/MS data was carried out using the software Lipid Data Analyzer (LDA) Version 2.8.1. LDA mass lists were generated for PLs and sphingolipids based on our previous studies [86]. LDA mass lists for NLs were created for all the neutral headgroups listed on LIPID MAPS. LDA exact mass lists were generated for diacylglycerols (DG), betaine diradylglycerols (DGTA), monogalactosyldiacylglycerol (MGDG), triacylglycerol (TG), alkyldiacylglycerols (TGO), and glycosyldiacylglycerols (HEXDG) using the following ranges: the molecular species with combined chain lengths of 24–44, 28–40, 24–38, 24–66, 37, and 45 respectively and degrees of unsaturation of 0–12 for all classes. Spectra from MS2 scans were used to validate LDA species identifications, which was also compared to LIPID MAPS product ion prediction tools. A relative quantification was used to compare between samples as it allowed us to internally control for sample size of thousands of worms while allowing for detection of fluctuations in less abundant species and produce reliable results. Supporting information Overlap between PA14-induced differentially expressed genes (DEGs) identified in this study and previously reported PA14-induced gene lists. A: All genes up- and down-regulated upon WT animals’ exposure to PA14 for 8 hours in this study compared with genes identified by Troemel et al. after 4 hours and 8 hours of exposure [27]. B-E: Comparisons of DEGs upregulated (B, D) or downregulated (C, E) on PA14 with genes identified by Shapira et al., 2006 (B, C) [26] and Twumasi-Boateng et al. 2012 (D, E) [47]. RF: Representation Factor. Statistical significance of overlap between gene sets calculated using hypergeometric probability formula with normal approximation (see Methods). (TIF) Global and category-specific transcriptional alterations induced by PA14 infection in WT and tcer-1 mutants identified using WormCat [48]. Analysis of gene expression changes in WT animals and tcer-1 mutants upon PA14 infection. Panels A and B show the global transcriptional response driven by infection (A) and genotype (B), while panels C-H detail category-specific changes in tcer-1 mutants on PA14 compared to WT animals on PA14. A: Bubble plot of genes upregulated (UP) or downregulated (right) in WT (N2) and tcer-1 mutants following PA14 exposure compared to OP50. Results of Categories 1, 2 and 3 are shown. B: Comparison of genes up- or downregulated in tcer-1 mutants relative to WT on OP50 or on PA14 infection. Upregulated genes (UP) and downregulated genes (right) are plotted across three categories as in A. C-H: Detailed breakdown of genes upregulated (C-E) or downregulated (F-H) in tcer-1 mutants versus WT under PA14 infection across three hierarchical categories, 1 (C, F), 2 (D, G) and 3 (E, H). Bubble size represents the number of genes in each WormCat category, and color intensity reflects statistical significance. (TIF) Categorical analysis of lipl-1p::mCherry expression. Fluorescence levels quantified based on area and observable intensity variation (see Methods). A, B: Intestinal Expression. A: Representative images of each category pseudocolored with ImageJ LUT Fire. Low- dim fluorescence primarily visible in posterior and anterior intestine. No areas of high intensity; posterior fluorescence limited to region near tail. Medium- posterior fluorescence between vulva and tail. Some areas of intermediate intensity in anterior intestine. High- posterior fluorescence uniformly extended up to the vulva or with multiple areas of bright intensity. Very High– posterior intestine with very bright fluorescence that extends into anterior half beyond the vulva and intermediate fluorescence extended at least to the vulva. Purple boxes indicate categories quantified in Fig 2E, 2F. B: Quantification of percent of population in each category. Data from 3 pooled biological replicates. EV: Empty vector control. (ev RNAi till L4 then OP50, 20°C, n = 81), (ev RNAi till L4 then PA14 20°C, n = 62), (tcer-1 RNAi till L4 then OP50, 20°C, n = 83), (tcer-1 RNAi till L4 then PA14 20°C, n = 41), (ev RNAi till L4 then OP50, 25°C, n = 82), (ev RNAi till L4 then PA14, 25°C, n = 69), (tcer-1 RNAi till L4 then OP50, 25°C, n = 84), (tcer-1 RNAi till L4 then PA14, 25°C, n = 68) C, D: Expression in Head Region. C: Representative images of each category pseudocolored with ImageJ LUT Fire. Low- No fluorescence visible. Medium- 1 or 2 puncta seen. High- More than 2 puncta, or diffuse, non-punctate expression. D: Quantification of data from 3 pooled biological replicates. (ev RNAi till L4 then OP50 20°C, n = 81), (ev RNAi till L4 then PA14 20°C, n = 62), (tcer-1 RNAi till L4 then OP50 20°C, n = 83), (tcer-1 RNAi till L4 then PA14 20°C, n = 41), (ev RNAi till L4 then OP50 25°C, n = 82), (ev RNAi till L4 then PA14 25°C, n = 69), (tcer-1 RNAi OP50 25°C, n = 84), (tcer-1 RNAi PA14 25°C, n = 67). (TIF) LIPL-1 and LIPL-2 protein levels observed using translational reporter strains lipl-1p::LIPL-1::RFP and lipl-2p::LIPL-2::RFP. A-D and E-H show representative images of Day 1 adults with lipl-1p::LIPL-1::RFP and lipl-2p::LIPL-2::RFP expression, respectively, that was predominantly seen in coelomocytes. Animals were raised on bacteria expressing control empty vector (Ctrl) or tcer-1 dsRNA (RNAi) until young adulthood, transferred to plates seeded with PA14 or OP50 bacteria and incubated for 8 hours at 25 °C. Images pseudocolored with ImageJ LUT RedHOT showing very low expression predominantly in coelomocytes (with high intestinal autofluorescence in E-H). (TIF) Categorical analysis of lipl-2p::mCherry expression. Expression levels in a population were variable and primarily observed in intestines. Fluorescence quantified based on area and observable intensity variation (see Methods). A, B: Intestinal Expression. A: Representative images of each category pseudocolored with ImageJ LUT Fire. Low- dim fluorescence primarily visible in posterior intestine limited to region between vulva and tail. Brighter fluorescence, if present, was restricted to tail. Medium- medium fluorescence in region between vulva and tail. Some area of increased intensity which extended past tail into anterior regions. High – broader posterior signal extending beyond vulva to anterior intestine with areas of bright intensity in posterior intestine. Very High– Intense fluorescence extended from posterior intestine to anterior of vulva. Purple boxes indicate categories quantified in elevated expression analysis in Fig 2K and 2L. B: Quantification of percent of population in each category. Data from 3 pooled biological replicates. EV: Empty vector control. (ev RNAi till L4 then OP50 20°C, n = 86), (ev RNAi till L4 then PA14 20°C, n = 81), (tcer-1 RNAi till L4 then OP50 20°C, n = 83), (tcer-1 RNAi PA14 till L4 then 25°C, n = 78), (ev RNAi till L4 then OP50 25°C, n = 87), (ev RNAi till L4 then PA14 25°C, n = 81), (tcer-1 RNAi till L4 then OP50 25°C, n = 90), (tcer-1 RNAi till L4 then PA14 25°C, n = 72) C: Expression dynamics across lifespan. Representative images of lipl-2p:mCherry expression in (from left to right) young larvae, L4 larvae, newly-hatched young adult, Day 1 adult, and Day 5 adult worms. Pseudocolored in ImageJ with LUT Fire. (TIF) Loss of tcer-1, lipl-1 and lipl-2 causes embryonic eggshell defects with age. Longitudinal analysis of BODIPY-permeable eggs laid by Day 1 (D1) and Day 4 (D4) mothers by different strains. WT (D1 0, n = 712; D4 0, n = 276), lipl-l (D1 0, n = 700; D4 0.4267, n = 703), lipl-2 (D1 0.0356, n = 2806; D4 0.9451, n = 529), tcer-1 (D1 0, n = 896; D4 0.3361, n = 596), tcer-1;lipl-1 (D1 0, n = 1456; D4 0.4687, n = 640), tcer-1;lipl-2 (D1 0.2212, n = 1356; D4 1.594, n = 439). (TIFF) Impact of lipl-1 and lipl-2 deletions on relative abundance of neutral lipid (NL) and phospholipid (PL) classes. Lipids from gravid Day 1 adults were analyzed using HPLC-MS/MS. A, B: Impact of lipl-1 (A) or lipl-2 (B) inactivation on relative abundance of NLs with > 2% abundance in total NL population. C, D: Relative abundance of PL categories altered by lipl-1 (C) or lipl-2 (D) inactivation. Statistical significance was calculated using two-way ANOVA with Tukey’s correction, p ≤ 0.05(*), p < 0.01 (**), < 0.001 (***), < 0.0001 (****). (TIFF) Impact of lipl-1 and lipl-2 deletions on saturation and fatty-acid chain length in neutral lipids. A, B: Relative abundance of double bonds (DB) in triacylglycerides (TAGs) altered by lipl-1 (A) or lipl-2 (B) inactivation. C, D: Relative abundance fatty-acid chain length (CL) of TAGs altered by lipl-1 (C) or lipl-2 (D) inactivation. Color key indicated on each panel. Statistical significance was calculated using two-way ANOVA with Tukey’s correction, p ≤ 0.05(*), p < 0.01 (**), < 0.001 (***), < 0.0001 (****). (TIFF) Impact of lipl-1 and lipl-2 deletions on saturation and fatty-acid chain length of phosphatidylcholine (PC) and phosphatidyl-ethanolamine (PE) lipids. A, B: Relative abundance of PC double bonds (DB) altered by lipl-1 (A) or lipl-2 (B) inactivation. C, D: Relative abundance of PC chain length (CL) altered by lipl-1 (C) or lipl-2 (D) inactivation. E, F: Relative abundance of PE double bonds altered by lipl-1 (E) or lipl-2 (F) inactivation. G, H: Relative abundance of PE chain length altered by lipl-1 (G) or lipl-2 (H) inactivation. Color key of different strains shown at top. Statistical significance was calculated using two-way ANOVA with Tukey’s correction, p ≤ 0.05(*), p < 0.01 (**), < 0.001 (***), < 0.0001 (****). (TIFF) Impact of lipl-1 and lipl-2 deletions on glucosyl-ceramides (GlcCer) and ceramides (Cer) lipids. A, B: Relative abundance of Cers altered by lipl-1 (A) or lipl-2 (B) inactivation. C, D: Relative Abundance of GlcCers altered by lipl-1 (C) or lipl-2 (D) inactivation. Color key of different strains shown at top. Statistical significance was calculated using two-way ANOVA with Tukey’s correction, p ≤ 0.05 (*), p < 0.01 (**), < 0.001 (***), < 0.0001 (****). (TIFF) Gene lists and GO-term analyses of differentially expressed genes identified by RNAseq in this study. (XLSX) Overlaps between PA14-induced genes identified in this study and previously reported PA14-driven genes. (XLSX) Survival of different strains upon PA14 infection. (PDF) Impact of lipl-1 and lipl-2 null mutants on lifespan on E. coli OP50. (PDF) Lipid species altered in tcer-1 mutants and the impacts of lipl-1 and lipl-2 mutations on these alterations. (PDF) Lipid species altered in lipl-1 and lipl-2 single mutants. (PDF) Survival of Cer 24 and LPC 18:2 supplemented strains upon PA14 infection. (PDF) Survival of strains expressing human LAL (hLAL/LIPA) in different genetic backgrounds on PA14. (PDF) Strains used in this study. (PDF) Primers used in this study. (PDF) 13 Aug 2025 PGENETICS-D-25-00799 LIPL-1 and LIPL-2 are TCER-1-regulated Lysosomal Lipases with Distinct Roles in Immunity and Fertility PLOS Genetics Dear Dr. Ghazi, Thank you for submitting your manuscript to PLOS Genetics. After careful consideration, we feel that it has merit but does not fully meet PLOS Genetics's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript within 30 days Sep 12 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosgenetics@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgenetics/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: * A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to formatting updates and technical items listed in the 'Journal Requirements' section below. * A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. * An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Jeremy Nance Academic Editor PLOS Genetics Pablo Wappner Section Editor PLOS Genetics Aimée Dudley Editor-in-Chief PLOS Genetics Anne Goriely Editor-in-Chief PLOS Genetics Journal Requirements: 1) Please ensure that the CRediT author contributions listed for every co-author are completed accurately and in full. At this stage, the following Authors/Authors require contributions: Paige Emily Silvia. Please ensure that the full contributions of each author are acknowledged in the "Add/Edit/Remove Authors" section of our submission form. The list of CRediT author contributions may be found here: https://journals.plos.org/plosgenetics/s/authorship#loc-author-contributions 2) We ask that a manuscript source file is provided at Revision. Please upload your manuscript file as a .doc, .docx, .rtf or .tex. If you are providing a .tex file, please upload it under the item type u2018LaTeX Source Fileu2019 and leave your .pdf version as the item type u2018Manuscriptu2019. 3) Please provide an Author Summary. This should appear in your manuscript between the Abstract (if applicable) and the Introduction, and should be 150-200 words long. The aim should be to make your findings accessible to a wide audience that includes both scientists and non-scientists. Sample summaries can be found on our website under Submission Guidelines: https://journals.plos.org/plosgenetics/s/submission-guidelines#loc-parts-of-a-submission 4) We noticed that you used the phrase 'data not shown' in the manuscript. We do not allow these references, as the PLOS data access policy requires that all data be either published with the manuscript or made available in a publicly accessible database. Please amend the supplementary material to include the referenced data or remove the references. 5) Please upload all main figures as separate Figure files in .tif or .eps format. For more information about how to convert and format your figure files please see our guidelines: https://journals.plos.org/plosgenetics/s/figures 6) We notice that your supplementary Figures, and Tables are included in the manuscript file. Please remove them and upload them with the file type 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list. 7) Please ensure that the funders and grant numbers match between the Financial Disclosure field and the Funding Information tab in your submission form. Note that the funders must be provided in the same order in both places as well. - State the initials, alongside each funding source, of each author to receive each grant. For example: "This work was supported by the National Institutes of Health (####### to AM; ###### to CJ) and the National Science Foundation (###### to AM)." - State what role the funders took in the study. If the funders had no role in your study, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.". If you did not receive any funding for this study, please simply state: u201cThe authors received no specific funding for this work.u201d Reviewers' comments: Reviewer's Responses to Questions Comments to the Authors: Please note here if the review is uploaded as an attachment. Reviewer #1: The study by Bahr et al. identifies LIPL-1 and LIPL-2 as lysosomal lipases functioning downstream of TCER-1, a transcriptional and splicing regulator that promotes fertility while suppressing immunity in C. elegans. Through transcriptomic, lipidomic, and genetic analyses, the authors demonstrate that these lipases have distinct, context-dependent roles in immunity, reproduction, lipid metabolism, and lifespan: LIPL-1 enhances immune resistance, whereas LIPL-2 primarily supports fertility. Importantly, the human ortholog LAL rescues lipl-1–associated immune defects, suggesting an evolutionarily conserved role in host defense. This work advances our understanding of conserved lipases in regulating immunity and development. I have several suggestions/questions to further improve the manuscript: 1. Are the translational reporters used in this study functional? Could the different promoter lengths used in various constructs influence the observed expression patterns? 2. The study reports lipl transgene expression in multiple tissues. In which tissues are lipl-1 and lipl-2 expression required and sufficient to produce the observed phenotypes? 3. Can supplementation with any lipid species identified in the lipidomics analysis rescue the infection or reproductive phenotypes in the mutant backgrounds? 4. Can the human homolog hLAL functionally replace lipl-2 as well? Does it also support reproductive function? 5. Adding a model figure summarizing the effects of each gene on immunity, reproduction, and lifespan would help synthesize the findings for readers. 6. There are inconsistencies in labeling double and triple mutants; the order of gene names should follow their chromosomal positions. tcer-1 is on chromosome II, while lipl-2 and lipl-1 are on chromosome V, with lipl-2 located earlier on the genetic map and therefore listed first. Promoter nomenclature should follow standard conventions, using gene name plus a lowercase p rather than a capital P. 7. Replace “normal” animals with “uninfected” animals for more precise language. 8. Remove references to “data not shown,” as PLOS does not permit this. Overall, this is an interesting and well-executed study. Addressing the points above would improve clarity, reproducibility, and adherence to journal standards. Reviewer #2: In this manuscript, Bahr et al. find that the expression of two lysosomal lipases, lipl-1 and lipl-2, changes in tcer-1 mutant animals, and show that these two genes have distinct activities and contribute to different tcer-1 mutant phenotypes. The authors identified lipl-1 and lipl-2 using RNAseq of tcer-1 mutants that were challenged with pathogenic Pseudomonas aeroginosa (PA). The abundance of the two lipl transcripts increase in wild-type animals challenged with PA. The induction of lipl genes is exaggerated in tcer-1 mutants, even though basal expression on non-pathogenic OP50 is reduced. The authors show that lipl-1 and lipl-2 mRNA are expressed in the intestine but that these proteins localize to coelomocytes, consistent with previous reports and studies of other lipl genes in C. elegans. Phenotypic analysis shows that lipl-1 is required for the increased survival of tcer-1 mutants when challenged with PA but does not change the survival of wild-type animals on PA. In contrast, loss of lipl-2 itself confers resistance to PA in wild-type animals similar to tcer-1 and there is no additive effect in the tcer-1; lipl-2 double mutant. The effects of lipl genes is specific to PA, as the lifespan of single and double mutants on OP50 was indistinguishable from wild-type. The authors also investigated the role of these lipl genes in fertility, as tcer-1 mutants are known to have reduced fertility. The authors show that loss of either lipl-1 or lipl-2 further reduces the number of progeny produced by tcer-1 mutants, but have no effect in the wild-type background. Closer examination showed that loss of either lipl gene increased embryonic lethality and sterility in tcer-1 mutants, and that loss of lipl-2 (but not lipl-1) increases the fraction of embryos with an intact permeability barrier. The authors next examine how the loss of the lipl genes changes the lipid profile of tcer-1 animals. The lipl genes are orthologues of the human lysosomal acid lipase (hLAL), and the authors show that hLAL can rescue the immunity defect of lipl-1 animals, suggesting some functions are conserved. Previous work from this group has demonstrated that TCER-1, an orthologue of the human transcription elongation and splicing factor TRCERG1, coordinates immunity, longevity, and fertility. This work shows that the effects of TCER-1 on immunity and fertility are mediated, in part, by regulation of LIPL-1 and LIPL-2. Moreover, the authors demonstrate that these two lipases have distinct physiological effects. This is an important finding that has implications in our understanding of mechanisms that underlie innate immunity, fat metabolism, reproductive fitness, and how these processes are coordinated. The data are rigorous and clearly presented, and this work will be of interest across fields. I think that this work would be even stronger if the authors could more clearly show that the changes they observe were functionally relevant. A couple of examples: * It is not clear if observed changes in embryo permeability are related to the fertility defect; whereas increased permeability is only observed in the tcer-1;lipl-2 double mutant, embryo viability, sterility, or brood size are all similarly reduced by lipl-1 and lipl-2. Moreover, the fraction of embryos permeable to dye (1.5% according to Fig S4) is much lower than the fraction of embryos that don’t hatch shown in Fig 5C. While it is certainly interesting that lipl-2 has this effect on permeability, It seems like there could be other tcer-1-associated changes that may be more germane to the effect on fertility observed. How do the authors explain the lack of correlation between permeability and the fertility defect they observe? Is it possible that the reduced brood size (Fig 5A) is reflecting a defect in sperm production or function? Does PA14 exposure exacerbate the permeability effect? * The authors show that there are some changes in the lipid profile of tcer-1 are related to lipl-1 and/or lipl-2, but there is no data to indicate which, if any, of these changes are functionally relevant. Neither lipl-1 nor lipl-2 impact the DAG or TAG of tcer-1 mutants (Fig 6A,B), suggesting that these are not relevant to the phenotypes of the double mutants. In contrast, there are some tcer-1-associated changes in lipids that do seem to be differently impacted by lipl-1 and lipl-2 (such as ceramides Cer17:1; O2/22:0 and Cer17:1; O2/24:0). It would be interesting to know if any of the tcer-1 immunity or fertility phenotypes are sensitive to orthogonal perturbations in these lipids. It would also be interesting to know how the authors are thinking about the pattern of lipid changes - why do some ceramides change, but not others? Why are some unsaturated lipids more affected than others? I would also like to raise some minor points that I hope the authors could address that I believe would improve the manuscript: * It’s not entirely clear to me how the authors identified the lipl genes from the RNAseq data presented. The way the manuscript is presented, it seemed that the authors were most interested in tcer-1-dependent, PA14 responsive transcriptional changes but it is a bit confusing which set of differentially expressed genes (DEG) they include in this set. The text suggests that the genes of interest would be included in the WT/PA14 vs tcer-1/PA14. However, some of these genes (including lipl-1 and lipl-2) are also included in the tcer-1/OP50 vs tcer-1/PA14 DEG, which the authors indicate are “tcer-1 independent” transcriptional responses. It could also be argued that the DEG in the wild-type PA14 response (WT/OP50 vs WT/PA14) that do not change in tcer-1 (OP50 vs PA14) are also “tcer-1-independent” responsive. * Do any of the other 6 lipl genes change in response to PA14? * I don’t understand why the authors didn’t use the DEG in PA14 that were tcer-1 dependent (WT/PA14 vs tcer-1/PA14) in the wormcat analysis shown in Fig 1G. The way these data are presented, there does not seem to be much difference in the WT and tcer-1 responses. It is really not clear how this result helped to identify the lipl genes. * It seems that in Fig 1I the authors statistically compare lipl-2 expression between WT/PA14 and tcer-1/OP50. It is not clear why this comparison would be considered instead of analyzing these data the same as for lipl-1 in Fig 1H. * The authors compare these RNAseq data to previous published transcriptomic analysis of PA14 responses. While there are significant overlaps in the genes that change in each data set, as expected, there are a lot of changes that do not overlap. Do the authors have an idea for why these data sets are so different? * The authors suggest that the LIPL reporters are expressed in the head of a small fraction of worms. I’m not convinced that this reflects the normal expression pattern of these genes, and I think including this observation in the main figures is somewhat misleading. Unless the authors want to do more experiments with relevant controls, I would recommend that they do not include pictures of these rare animals in the figures. Similarly, the author claim that this low and uncommon expression is in neurons but it seems that it might also be hypodermis or pharynx. This should be corrected unless the authors can show colocalization with a neuronal marker. * The authors show images of a single worm to support their claims in Fig 2, SFig 2, Fig 3, and SFig 3. Especially when there is not a quantitation of a population, showing a single worm is not sufficient of the reader to evaluate if these data support the stated conclusions. * It is not clear how many independent replicates were done for lifespan experiments, or if the Figure shows a single experiment or if it is an aggregation of all replicates. This should be made clear in the figure legend, and summary statistics for all replicates should be included in the Supplementary Materials (mean survival, max survival, # animals, # censored, etc). * In Fig 5, the authors claim to measure the “hatch rate”, but this is not a rate measurement, it is just the fraction of the eggs that hatch. It is also not clear how the authors defined “sterility” for the data shown in Fig 5B. * It is not clear how many replicates are included in the lipidomics experiments and this makes it difficult to interpret the data. Many of the changes seem pretty small, and it would be useful to know how the abundance varies across samples to have a better understanding of the robustness of the changes that are noted. * Is the hLAL protein also localized to the coelomocytes? Other work suggests that localization to coelomocytes is important for LPL function (Buis et al 2019) - is this true for tcer-1 associated effects of lipl-1 and/or lipl-2? * On page 20 it would be good to include the relevant reference where the plipl-2::LIPL-2::RFP transgenic strain was first characterized. * There are some unformatted citations on pg 24, 28, and 29. * In the materials and methods the authors should replace “u” with the greek mu where appropriate * For pathogen exposure experiments, how many independent replicates were performed? Is the data shown in the figures aggregated data or a representative experiment? The authors should include this information in the legends, and also provide summary statistics for independent replicates in the supplementary material. Also, the authors mention S. aureus in the methods section but I don’t think any of these experiments is included in this manuscript. * The authors used FuDR to prevent egg hatching on PA14, but don’t show controls to make sure that FuDR doesn’t affect the results of these assays. It would be nice to see this control. * For experiments comparing transgene expression, what calibrations were performed to ensure that comparisons between samples are valid? Also, were the samples blinded in any way before the assay? * In the materials and methods the authors suggest that they separated young adults from other stages for lipidomics experiments with strains that were not easily synchronized. Was this done manually? It is not clear what exactly was done to achieve this. Reviewer #3: Using the C. elegans model, Bahr et al. investigate the role of two lipases, LIPL-1 and -2 in the regulation of life span, immune responses, and reproduction, both in wild type worms in the tcer-1 mutant background. Deploying lipidomic, trascriptomic, and genetic (mutant/rescue and reporter) approaches they find that these two lipases are regulated substantially in tcer-1 mutants and after infection with the Pseudomonas aerigunosa strain PA14. Despite the similar regulation of both genes, their loss of function causes disparate effects, with lipl-1 required for the enhanced resistance of tcer-1 to pathogen, and tcer-2 for the life span phenotype. Both genes showed defects, and synthetic effects on various parameters of reproduction. Excitingly, lipidomics revealed some distinct changes between lipl-1 and -2, for example the blocked induction of 3 ceramide species by lipl-1 mutation in the tcer-1 context. Finally, the authors showed that the human LIPL ortholog, hLAL, could rescue the defective pathogen resistance caused by lipl-1 mutation. This study provides important new insight into both the phenotypes and underlying molecular lipid defects of two lipases and should be of interest to researchers studying gene regulation, metabolism, immune responses, and reproduction. The experiments are overall well done and very comprehensive. Comments: - It would be exciting to be able to show whether the deregulated ceramide species can be supplemented to rescue the defects in immune defence; I appreciate that this may be a challenging experiment however. - I was surprised that the authors didn’t also attempt to test whether hLAL also rescues lipl-2 mutant phenotypes - Results P13: conclusion "lipl-2 single mutants also showed a similar change in TAG:DAG distribution which was further aggravated in tcer-1;lipl-2 double mutants.” Differences between the double and the singles appear minor and not stats are shown - did the authors mean to write distribution was NOT further aggravated? I would reason that that is what’s supported by the data and statistics Typos - Abstract: "lipl-l” - Intro p4: “Arabidopsis” add “thaliana” - Results p9: "LIPL-1::RFP expression showed similar spatial distribution as the mRNA” - GFP reporters measure promoter activity, not mRNA. Rephrase. - Results p12: "the lipl-1 or lipl-1 mutations” - Results p12 “even reproductively older Day 4” sounds odd - aren’t they simply “older”? - Results p15 "LPC 18: 2” delete space - P18 discussion: “lOur" ********** Have all data underlying the figures and results presented in the manuscript been provided? Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy , and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information. Reviewer #1: None Reviewer #2: Yes Reviewer #3: No: RNA-seq data should be deposited in GEO or similar. Lipidomics data should be deposited in a similarly accessible databank ********** PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] Figure resubmission: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. If there are other versions of figure files still present in your submission file inventory at resubmission, please replace them with the PACE-processed versions. Reproducibility: To enhance the reproducibility of your results, we recommend that authors deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols 4 Nov 2025 Submitted filename: BahrEtal_Resp_Reviewers.pdf 18 Nov 2025 Dear Dr Ghazi, We are pleased to inform you that your manuscript entitled "LIPL-1 and LIPL-2 are TCER-1-regulated Lysosomal Lipases with Distinct Roles in Immunity and Fertility" has been editorially accepted for publication in PLOS Genetics. Congratulations! Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made. Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org. In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date. Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics! Yours sincerely, Jeremy Nance Academic Editor PLOS Genetics Pablo Wappner Section Editor PLOS Genetics Aimée Dudley Editor-in-Chief PLOS Genetics Anne Goriely Editor-in-Chief PLOS Genetics www.plosgenetics.org BlueSky: @plos.bsky.social ---------------------------------------------------- Comments from the reviewers (if applicable): Reviewer's Responses to Questions Comments to the Authors: Please note here if the review is uploaded as an attachment. Reviewer #1: I would like to thank authors for addressing all my comments/questions. Reviewer #2: The authors have addressed every point that I raised, and the issues raised by the other reviewers, and I think the manuscript is improved. I recommend it be accepted for publication. Reviewer #3: The reviewers have addressed all my comments to satisfaction. Congrats on a very nice paper! ********** Have all data underlying the figures and results presented in the manuscript been provided? Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy , and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information. Reviewer #1: None Reviewer #2: Yes Reviewer #3: No: Not sure if large scale RNA-seq and lipidomics datasets have been deposited in relevant databases ********** PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #2: No Reviewer #3: No ---------------------------------------------------- Data Deposition If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository . As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website . The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-25-00799R1 More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support. Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present. ---------------------------------------------------- Press Queries If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org . PGENETICS-D-25-00799R1 LIPL-1 and LIPL-2 are TCER-1-regulated Lysosomal Lipases with Distinct Roles in Immunity and Fertility Dear Dr Ghazi, We are pleased to inform you that your manuscript entitled "LIPL-1 and LIPL-2 are TCER-1-regulated Lysosomal Lipases with Distinct Roles in Immunity and Fertility" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. For Research Articles, you will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work! With kind regards, Narmatha Raju, M.Sc PLOS Genetics On behalf of: The PLOS Genetics Team Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom plosgenetics@plos.org | +44 (0) 1223-442823 plosgenetics.org | Twitter: @PLOSGenetics